GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.

Google issues cybersecurity warning as hackers exploit AI to steal passwords. FDA warns against unapproved sunscreens. Lilly ...

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...

Actor Christopher Biggins has revealed he is using weight loss jabs as he needed to lose weight after having surgery on his ...

Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...

The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Actor Christopher Biggins has revealed he is using weight loss jabs as he needed to lose weight after having surgery on his ...

Actor Christopher Biggins has revealed he is using weight loss jabs as he needed to lose weight after having surgery on his ...

Shares in Novo Nordisk rose as much as 5% in early European trading Monday, regaining some ground after losing more than half of their value over the past year.

THE NHS is set to dish out Mounjaro prescriptions to more patients, as private clinics prepare to double their prices from ...

Over 2,000 Ozempic and Zepbound lawsuits allege life-threatening side effects as FDA updates warnings and courts weigh ...